Balance Sheet Data
Emergent BioSolutions Inc. (EBS)
$35.33
+3.64 (+11.49%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 178.29 | 112.20 | 167.80 | 621.30 | 576.10 | 641.71 | 861.09 | 1,155.47 | 1,550.49 | 2,080.54 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 146.08 | 271.10 | 275.30 | 230.90 | 274.70 | 556.91 | 747.30 | 1,002.78 | 1,345.60 | 1,805.61 |
| Account Receivables (%) | ||||||||||
| Inventories | 142.81 | 205.80 | 222.50 | 307 | 350.80 | 534.95 | 717.83 | 963.23 | 1,292.52 | 1,734.39 |
| Inventories (%) | ||||||||||
| Accounts Payable | 41.75 | 80.70 | 94.80 | 136.10 | 128.90 | 203.37 | 272.89 | 366.18 | 491.37 | 659.35 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -54.83 | -72.10 | -86.90 | -141 | -225 | -233.17 | -312.88 | -419.84 | -563.37 | -755.96 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.